Your browser doesn't support javascript.
loading
Nanomaterials in tuberculosis DNA vaccine delivery: historical perspective and current landscape.
Luo, Xing; Zeng, Xiaoqiang; Gong, Li; Ye, Yan; Sun, Cun; Chen, Ting; Zhang, Zelong; Tao, Yikun; Zeng, Hao; Zou, Quanming; Yang, Yun; Li, Jieping; Sun, Hongwu.
Afiliação
  • Luo X; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Zeng X; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Gong L; Department of Laboratory Medicine, Third Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Ye Y; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Sun C; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Chen T; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Zhang Z; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Tao Y; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Zeng H; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Zou Q; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Yang Y; National Engineering Research Centre of Immunological Products, Department of Microbiology and Biochemical Pharmacy, College of Pharmacy, Third Military Medical University, Chongqing, China.
  • Li J; Department of Hematology Oncology, Chongqing University Cancer Hospital, Chongqing, China.
  • Sun H; Department of Hematology, Changsha Central Hospital, Changsha, China.
Drug Deliv ; 29(1): 2912-2924, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36081335
ABSTRACT
Vaccinations, especially DNA vaccines that promote host immunity, are the most effective interventions for tuberculosis (TB) control. However, the vaccine delivery system exhibits a significant impact on the protective effects of the vaccine. Recently, effective nanomaterial-based delivery systems (including nanoparticles, nanogold, nanoliposomes, virus-like particles, and virus carriers) have been developed for DNA vaccines to control TB. This review highlights the historical development of various nanomaterial-based delivery systems for TB DNA vaccines, along with the emerging technologies. Nanomaterial-based vaccine delivery systems could enhance the efficacy of TB vaccination; therefore, this summary could guide nanomaterial selection for optimal and safe vaccine delivery, facilitating the design and development of highly effective TB vaccines.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Vacinas de DNA / Vacinas contra a Tuberculose / Nanoestruturas / Mycobacterium tuberculosis Limite: Humans Idioma: En Revista: Drug Deliv Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tuberculose / Vacinas de DNA / Vacinas contra a Tuberculose / Nanoestruturas / Mycobacterium tuberculosis Limite: Humans Idioma: En Revista: Drug Deliv Assunto da revista: FARMACOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China